McGill Genome Centre
The McGill Genome Centre is an academic multi-omics core facility at McGill University offering integrated genomics, proteomics, metabolomics, single-cell, spatial, and bioinformatics services to academic researchers, pharmaceutical/biotech firms, and clinical researchers via a cost-recovery, fee-for-service model with PhD-level project management.
- Company typePrivate
- Founded-
- HeadquartersMontreal, Canada
- Headcount11–50
- GTM typeB2B
- OfferingServices
What McGill Genome Centre does
The McGill Genome Centre is an academic core research facility operating as the technology and discovery engine of the Victor Phillip Dahdaleh Institute of Genomic Medicine at McGill University in Montreal, Quebec. It delivers integrated multi-omics services across eight core platforms: sequencing (short-read via Illumina iSeq/MiSeq/NovaSeq 6000/NovaSeq X Plus and Ultima UG 100; long-read via PacBio Revio and Oxford Nanopore PromethION P48), proteomics (Olink PEA and SomaScan/SomaSeq aptamer-based — up to ~11,000 protein targets), single-cell sequencing (10x Genomics Chromium, plate-based SmartSeq4/Hive), metabolomics and lipidomics (Shimadzu LCMS/GCMS triple quads, Orbitrap Exploris 240), spatial multiomics (NanoString GeoMx DSP, CosMx SMI, 10x Xenium/Visium HD), genotyping (Illumina/Affymetrix microarrays, Fluidigm SNPType), technology development (Hi-C, PhIP-Seq), and bioinformatics powered by the Canadian Centre for Computational Genomics (C3G) via the GenPipes workflow system and Abacus HPC cluster. Proprietary infrastructure includes the Hercules web-based project submission portal built with McGill Med-IT.
The centre operates on a cost-recovery, fee-for-service academic model. Customers request quotes through the Hercules portal or by contacting PhD-level project managers (the MAGIC team), who guide experimental design, technology selection, and execution. Standard projects complete within 4–8 weeks. Pricing is quote-based and not publicly disclosed. The customer base spans academic researchers (primary), pharmaceutical and biotechnology companies (primary), and healthcare/clinical researchers (secondary), with the C3G having supported over 1,300 analysis projects and 700+ research groups across Canada and internationally since 2011. The facility is led by Scientific Director Mark Lathrop, with platform leadership across genome sciences, bioinformatics, and operations, and is structurally embedded within McGill University rather than operating as an independent commercial entity.
McGill Genome Centre firmographics
Firmographics- Name
- McGill Genome Centre
- Legal name
- McGill Genome Centre
- Website
- https://mcgillgenomecentre.ca
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- The McGill Genome Centre is an academic multi-omics core facility at McGill University offering integrated genomics, proteomics, metabolomics, single-cell, spatial, and bioinformatics services to academic researchers, pharmaceutical/biotech firms, and clinical researchers via a cost-recovery, fee-for-service model with PhD-level project management.
- Ownership category
- akta.pro rank
McGill Genome Centre industry classification
Industry- Product category
- Multi-omics Research Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI)
- akta.pro secondary industries
- Transcriptomics & Gene Expression Profiling Services (HLAGANAE), Proteomics & Mass Spectrometry Services (HLAGANAB), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD)
Keywords
Where McGill Genome Centre is headquartered
LocationHeadquarters
- HQ city
- Montreal
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
McGill Genome Centre business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations, Supply Chain
Revenue model
- Multi-omics research services: The McGill Genome Centre operates as a cost-recovery academic core facility providing fee-for-service genomics, proteomics, metabolomics, and bioinformatics services to researchers. Projects are quoted individually based on scope and technology requirements, with pricing determined through the Hercules portal consultation process.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Quote-based service pricing |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
McGill Genome Centre product offering
Product offeringCore offering
The McGill Genome Centre operates as an integrated multi-omics research core facility providing fee-for-service genomics, proteomics, metabolomics, and bioinformatics to academic and industry researchers. It delivers end-to-end support from experimental design and technology selection through sample processing and data analysis, coordinated by PhD-level project managers. Services span short-read and long-read sequencing, single-cell and spatial analysis, high-throughput proteomics, mass spectrometry–based metabolomics, and computational analysis via the Canadian Centre for Computational Genomics (C3G).
Product overview
McGill Genome Centre operates as an integrated multi-omics research platform offering a portfolio of interconnected services spanning genomics, proteomics, metabolomics, and bioinformatics. The core offerings include the Sequencing Platform (short-read via Illumina/Ultima and long-read via PacBio/Nanopore), Bioinformatics Platform (powered by C3G with GenPipes pipelines), Proteomics Platform (Olink PEA and SomaScan/SomaSeq aptamer-based), Single-Cell Sequencing (10x Genomics Chromium and plate-based), Metabolomics and Lipidomics Platform (Shimadzu and Orbitrap-based), Spatial Multiomics Platform (NanoString GeoMx, CosMx, 10X Visium/Xenium), Genotyping Platform (Illumina/Affymetrix microarrays), and Technology Development for advanced applications (Hi-C, PhIP-Seq). Services are unified through the Hercules web portal for project management and coordinated by MAGIC project managers, with computational support from C3G.
Differentiator
Problem solved
Functional benefit
Products and services
- Sequencing Platform High-throughput multi-technology sequencing platform combining short-read (Illumina iSeq100, MiSeq, NovaSeq 6000, NovaSeq X Plus, Ultima UG 100) and long-read (PacBio Revio, Oxford Nanopore PromethION P48) platforms supporting WGS, WES, RNA-Seq, metagenomics, structural variant detection, hybrid assembly, haplotype phasing, and de novo assembly.
- Bioinformatics Platform Computational analysis services powered by the Canadian Centre for Computational Genomics (C3G), providing standardized and custom pipelines for variant calling, transcriptomics, epigenomics, metagenomics, cancer genomics, and multi-omic integration, with access to the Abacus HPC cluster and GenPipes workflow management system.
- Proteomics Platform Large-scale targeted proteomics platform using Olink PEA-based (Explore HT measuring 5,416 proteins, Reveal, Target 96/48, Flex) and SomaScan/SomaSeq aptamer-based (~11,000 protein targets) technologies for biomarker discovery and protein profiling.
- Single-Cell Sequencing Single-cell analysis platform using 10x Genomics Chromium (droplet-based) and plate-based SmartSeq4 and Hive platforms for scRNA-Seq, ATAC-seq, Multiome (RNA+ATAC), immune repertoire sequencing, CNV analysis, and CITE-seq.
- Metabolomics and Lipidomics Platform Quantitative profiling of small molecules using Shimadzu LCMS TQ-8060NX, GCMS TQ-8040NX, and Orbitrap Exploris 240 for targeted metabolomics (497+ metabolites via GC-MS/MS, 369+ via LC-MS/MS) and untargeted lipidomics (~500 detectable lipids from plasma samples).
- Spatial Multiomics Platform Spatial transcriptomics and proteomics enabling high-resolution mapping of RNA and protein expression within intact tissue sections using NanoString GeoMx Digital Spatial Profiler, CosMx SMI, 10x Genomics Xenium, and Visium HD technologies.
- Genotyping Platform Microarray-based genotyping and DNA methylation analysis using Illumina (iScan, Infinium, EPIC), Affymetrix Axiom, Fluidigm SNPType, and TaqMan assays for GWAS, population genetics, pharmacogenomics, and targeted SNP genotyping.
- Hercules Project Submission Portal Secure web-based portal for project submission developed by McGill Med-IT and the McGill Genome Centre, enabling external researchers to submit project requests, upload sample manifests and purchase orders, receive service quotations, and track project status in real time.
- Project Management Services (MAGIC) PhD-level project management support provided by MAGIC (McGill Applied Genomics Innovation Core) for experimental design, technology selection, workflow coordination, and project execution across all platforms.
Quantifiable outcome
- Projects typically completed within 4-8 weeks depending on scope
- +4 more outcomes
Companies that use McGill Genome Centre
Customer profileSegments3 records
Ideal customer profiles3 records
McGill Genome Centre technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
McGill Genome Centre partnerships and signals
Strategic signalPartnerships
21 partnerships are on record, tiered core and supporting.
- IlluminacoreIllumina is a key technology partner providing short-read sequencing platforms (iSeq100, MiSeq, NovaSeq 6000, NovaSeq X Plus) and microarray technologies (Infinium, EPIC) for the centre's genomics and genotyping services.
- Olink ProteomicscoreOlink provides PEA-based proteomics solutions including Explore HT (5,416 proteins), Reveal, Target 96/48, and Flex panels for high-throughput protein profiling.
- Pacific Biosciences (PacBio)corePacBio Revio long-read sequencing platform is offered for de novo genome assembly, structural variant detection, haplotype phasing, and epigenetic modification detection.
- Oxford Nanopore TechnologiescoreOxford Nanopore PromethION P48 platform enables scalable, high-throughput long-read sequencing with capabilities for ultra-long reads, small genome sequencing, full-length RNA-seq, and native methylation detection.
- 10x Genomicscore10x Genomics Chromium platform supports single-cell 3'/5' RNA-Seq, ATAC-seq, Multiome, CITE-seq, and Fixed RNA Profiling. Xenium and Visium HD platforms are used for spatial transcriptomics.
- SomaLogiccoreSomaScan Discovery (aptamer-based, ~11,000 proteins) and SomaSeq Discovery (aptamer-based with NGS quantification, ~9,500 proteins) platforms enable broad-discovery proteomics applications.
- ShimadzucoreShimadzu LCMS TQ-8060NX and GCMS TQ-8040NX triple quadrupole mass spectrometers support targeted metabolomics via LC-MS/MS and GC-MS/MS for quantifying amino acids, organic acids, bile acids, and other metabolites.
- Thermo Fisher ScientificcoreThermo Fisher provides Affymetrix Axiom microarrays for high-density SNP genotyping, Fluidigm SNPType for targeted SNP genotyping, and the Orbitrap Exploris 240 for untargeted lipidomics.
- NanoString/Bruker Spatial BiologycoreNanoString/Bruker Spatial Biology provides GeoMx Digital Spatial Profiler and CosMx SMI platforms for spatially resolved transcriptomics and proteomics profiling within intact tissue architecture.
- Canadian Centre for Computational Genomics (C3G)coreC3G provides the computational backbone for all Genome Centre projects, offering standardized pipelines and custom bioinformatics tailored to each study. Led by Dr. Guillaume Bourque, C3G is a national bioinformatics infrastructure platform.
- Advanced Genomic Technologies (AGT)coreAGT laboratory provides specialized single-cell and long-read sequencing services, including technology evaluation and implementation of emerging sequencing technologies and tools for single-cell, long-read, and spatial genomics.
- Ultima GenomicssupportingUltima Genomics UG 100 platform offers cost-efficient WGS and pooled designs for population-scale or high-throughput transcriptome studies.
- QiagensupportingQiagen provides additional technology solutions for multi-omics research as part of the centre's partner ecosystem.
- RevvitysupportingRevvity provides technology solutions as part of the centre's multi-omics partner ecosystem.
- Beckman CoultersupportingBeckman Coulter provides laboratory technology solutions supporting the centre's research infrastructure.
- Agilent TechnologiessupportingAgilent provides technology solutions as part of the centre's multi-omics partner ecosystem.
- Integrated DNA Technologies (IDT)supportingIDT provides technology solutions for genomic research as part of the centre's partner ecosystem.
- New England Biolabs (NEB)supportingNEB provides technology solutions as part of the centre's multi-omics partner ecosystem.
- BioModalsupportingBioModal provides technology solutions as part of the centre's multi-omics partner ecosystem.
- Secure Data for Health (SD4H)coreSD4H provides Quebec-based secure cloud infrastructure for privacy-compliant health and genomics data analysis, supporting the centre's bioinformatics platform.
- Calcul Québec–AlliancecoreCalcul Québec–Alliance network provides high-performance computing infrastructure supporting the centre's large-scale data analysis capabilities.
Scale indicators2 records
Recent moves5 records
Expansion highlights4 records
McGill Genome Centre competitors and assessment
Company assessmentDirect peers
- Génome Québec: Quebec-based non-profit genomic research centre with sequencing and bioinformatics service offerings. Comparable as a regional Canadian academic service provider with overlapping customer segments and technology stack.
- HudsonAlpha Institute for Biotechnology: Non-profit genomics and clinical services institute offering short-read and long-read sequencing, clinical genomics, and bioinformatics to academic and clinical customers. Comparable as a non-profit core offering multi-omics services.
- The Centre for Applied Genomics (TCAG): TCAG at the Hospital for Sick Children in Toronto is a Canadian academic genomics core facility offering sequencing, genotyping, and bioinformatics services to researchers. It is the closest direct Canadian peer to McGill Genome Centre in scope, service model, and customer base.
- New York Genome Center: Non-profit academic genomics centre jointly operated by leading New York institutions, offering short-read and long-read sequencing, single-cell, spatial, and bioinformatics. Closely comparable service portfolio and cross-omics integration.
- Ontario Institute for Cancer Research (OICR): Ontario-based translational cancer research institute with genomics, informatics, and clinical diagnostics capabilities. Comparable in operating model as a Canadian academic scientific service organization with multi-omics offerings.
- Canada's Michael Smith Genome Sciences Centre: BC-based academic genome centre providing high-throughput sequencing, bioinformatics, and technology development to national and international research consortia. Directly comparable in mission, scale, and multi-platform offering.
Broad incumbents
- Broad Institute: Elite Harvard/MIT-affiliated genomics institute with extensive sequencing, proteomics (via the Proteomics Platform), single-cell, and bioinformatics capacity. A much larger incumbent in the same multi-omics academic service space.
- Azenta Life Sciences (formerly GENEWIZ): Commercial genomics CRO offering Sanger, next-generation sequencing, and synthetic biology services to researchers, including GLP/cGMP offerings. Comparable sequencing and multi-omics service catalog but with a commercial, catalog-driven model.
- Wellcome Sanger Institute: UK-based genomics institute operating large-scale sequencing, single-cell, and bioinformatics platforms for global research consortia. Comparable institutional mission and broad multi-omics offering at significantly greater scale.
- Novogene: Large commercial genomics service provider offering short-read and long-read sequencing, single-cell, and bioinformatics globally. Comparable in underlying technology stack but competing on commercial scale and standard pricing rather than academic affiliation.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
McGill Genome Centre social profiles
Digital presenceMcGill Genome Centre financial estimates
Financial estimateRevenue estimate
Valuation estimate
McGill Genome Centre leadership team
Management profileNumber of profiles
Profiles4 records
McGill Genome Centre funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
McGill Genome Centre M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about McGill Genome Centre
What does McGill Genome Centre do?
The McGill Genome Centre operates as an integrated multi-omics research core facility providing fee-for-service genomics, proteomics, metabolomics, and bioinformatics to academic and industry researchers. It delivers end-to-end support from experimental design and technology selection through sample processing and data analysis, coordinated by PhD-level project managers. Services span short-read and long-read sequencing, single-cell and spatial analysis, high-throughput proteomics, mass spectrometry–based metabolomics, and computational analysis via the Canadian Centre for Computational Genomics (C3G).
Is McGill Genome Centre a public or private company?
McGill Genome Centre is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was McGill Genome Centre founded?
McGill Genome Centre was founded in -1. It employs 11 to 50 people.
Where is McGill Genome Centre based?
McGill Genome Centre is headquartered in Montreal, Canada, in the North America region.
How does McGill Genome Centre make money?
One revenue line is on record: multi-omics research services.
Who are McGill Genome Centre's main competitors?
Direct peers on record are Génome Québec, HudsonAlpha Institute for Biotechnology, The Centre for Applied Genomics (TCAG), New York Genome Center, Ontario Institute for Cancer Research (OICR) and Canada's Michael Smith Genome Sciences Centre. Broad incumbents are Broad Institute, Azenta Life Sciences (formerly GENEWIZ), Wellcome Sanger Institute and Novogene.
Does McGill Genome Centre have an API?
No public API is recorded for McGill Genome Centre.
What industry is McGill Genome Centre in?
McGill Genome Centre's product category is Multi-omics Research Services. Its primary akta.pro industry code is HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services, with a secondary code of HLAGANAE, Transcriptomics & Gene Expression Profiling Services. Its NAICS code is 5417 and its SIC code is 8731.